Journal of Clinical Endocrinology & Metabolism

Article	Citations
Correction to “Recent Insights into Noncoding RNAs in Primary Ovarian Insufficiency: Focus on Mechanisms and Treatments”	651
Correction to: “Associations of Serum Vitamin B6 Status and Catabolism With All-Cause Mortality in Patients With T2DM”	409
Correction to: “Critical Approach to Hypothyroid Patients With Persistent Symptoms”	274
Response to Letter to the Editor From Jagannath and Mayilvaganan: “FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography”	239
Response to Letter to the Editor From de Zegher and Ibáñez: “Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis”	179
A Step Toward Disentangling the Complex Relationship Between Vitamin D and Kidney Function	165
Correction to: “Contralateral Suppression in Adrenal Venous Sampling Predicts Clinical and Biochemical Outcome in Primary Aldosteronism”	130
Response to Letter to the Editor From Sukor and Kamaruddin: “Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation”	110
Anti-Androgen and Aromatase Inhibitor Do Not Enhance Height in Children With CAH	101
Iodineminho Study: Iodine Supplementation and Prevalence of Iodine Deficiency In Pregnant Women	100
Signs of Potential Androgen Excess Across the Lifespan in a US-based Digital Cohort Study	90
Insights on Improving Health Insurance Literacy in Diabetes	90
Clinical and Molecular Genetic Characteristics of Patients with Hereditary Hypophosphatemia	87
Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade	86
Correction to: “Vitamin D Status, Vitamin D Receptor Polymorphisms, and Risk of Type 2 Diabetes: A Prospective Cohort Study”	83
Changes in Collagen Type I C-Telopeptide and Procollagen Type I N-Terminal Propeptide During the Menopause Transition	78
GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1	78
Signs of a Glucose- and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes	78
Response to Letter to the Editor From Hasebe and Su: “Adrenalectomy Reduces the Risk of Vertebral Fractures in Patients With Mild Autonomous Cortisol Secretion”	77
Serum 25-Hydroxyvitamin D is Associated With Bone Microarchitecture and Strength in a Multiracial Cohort of Young Adults	75
Further Data Against the Use of Cyproterone Acetate in Gender-Affirming Hormone Therapy Regimens	73
Correction to: “Triglyceride–Glucose Index and Risks of All-Cause and Cause-Specific Mortality in Young Adults”	70
Correction to: “Metabolic Profiles of Pregnancy With Polycystic Ovary Syndrome: Insights into Maternal-Fetal Metabolic Communication”	70
Correction to: “Determinants of Pancreatic Size and Fat Content in the UK Biobank: Influence of Race, Genetic Variants, and Risk Factors”	69
Transitions in Metabolic Health Status and Obesity Over Time and Risk of Diabetes: The Dongfeng–Tongji Cohort Study	69

Characterizing 24-Hour Skeletal Muscle Gene Expression Alongside Metabolic and Endocrine Responses Under Diurnal Conditions	68
Glycemic, Cardiorenal, and Weight Implications on Noninsulin Pharmacotherapy for the Management of Type 2 Diabetes	68
Stable Iodine Intake and Thyroid Screening Outcomes After the Fukushima Nuclear Disaster: An Observational Study	67
Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement Therapy	67
Current Recommended Estrogen Dosing for Pubertal Induction in Turner Syndrome Results in Normal Uterine Growth	66
Correction to “Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study”	64
Time to Increase Awareness and Diagnosis of Steatotic Liver Disease in Adolescents	63
Correction to: “Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline”	62
Association of Age at Menarche With Inflammation and Glucose Metabolism Biomarkers in US Adult Women: NHANES 1999-2018	60
Approach to the Patient: Type 1 Diabetes Management With Exercise—Prepare, Perform, Stabilize, and Study	59
Type 2 Diabetes Remission: Achieving Calorie Restriction and Weight Loss by Any Which Way?	58
New Treatments for Acromegaly in Development	57
Turner's Syndrome, Glucagon-like Peptide 1, and Glucose-dependent Insulinotropic Polypeptide Agents: Silver Bullets?	57
Initial Evaluation of Radioiodine Therapy Using Imaging for Long-term Prognosis in Thyroid Cancer: A Retrospective Study	57
The Diagnostic Value of 18F-FDG PET/CT Scan in Characterizing Adrenal Tumors	57
Dehydroepiandrosterone Sulfate and Mortality in Middle-Aged and Older Men and Women—A J-shaped Relationship	57
Gender-Affirming Treatment and Employment Rate in 3812 Danish Transgender Persons and 38 120 Controls	57
Hemoglobin Glycation Index: A Novel Risk Factor for Incident Chronic Kidney Disease in an Apparently Healthy Population	57
Tracking and Cumulative Lifetime Exposure to IGF-I in 6459 Healthy Individuals and in SGA Children Treated With GH	56
Association Between Urinary Phthalate Metabolites and Sarcopenia in US Adults From NHANES 2011-2018	56
Suppression of Endogenous Insulin Secretion by Euglycemic Hyperinsulinemia	56
Effect of Anamorelin, a Ghrelin Receptor Agonist, on Muscle and Bone in Adults With Osteosarcopenia	55
Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy	55
Association of Thyroid Dysfunction in Individuals ≥ 65 Years of Age With Subclinical Cardiac Abnormalities	55
Association of Circulating Very Long-Chain Saturated Fatty Acids With Cardiovascular Mortality in NHANES 2003-2004, 2011-2012	54
Growth Patterns of Children With Short Stature in Adulthood According to Auxological Status and Maturity at Birth	54
Sex Steroids and Women’s Physical Performance in Midlife: Findings From the Menarche-To-PreMenopause Study	53
Mesenteric Visceral Lipectomy Improves Glucose Tolerance in Patients With Type 2 Diabetes: A Pilot Study	53
Effect of Liraglutide Treatment on Whole-body Glucose Fluxes in C-peptide–Positive Type 1 Diabetes During Hypoglycemia	52
Ectopic Cervical Thymoma in a Patient Diagnosed With Graves Disease: A Systematic Literature Review	52
Circulating miRNAs Respond to Denosumab Treatment After 2 Years in Postmenopausal Women With Osteoporosis—the MiDeTe study	50
Circulating Inflammatory Cytokines and Female Reproductive Diseases: A Mendelian Randomization Analysis	49
Approach to the Patient With Primary Aldosteronism: Role of Molecular Imaging	48
Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12	47
Novel Associations of Empagliflozin on the Gut Microbiome and Metabolome in Type 2 Diabetes	47
Clinical use of Molecular Data in Thyroid Nodules and Cancer	46
The Association of Adiposity and RAAS With Incident Diabetes in African Americans: The Jackson Heart Study	46
Approach to the Patient: Management of bone fragility in patients with chronic hypoparathyroidism	46
Demographic, Healthcare Access, and Dietary Factors Associated With Thyroid Hormone Treatments for Hypothyroidism	46
A Review of Hot Flash Management in Patients With Prostate Cancer	46
Influence of Maternal Exercise on Glucose and Lipid Metabolism in Offspring Stem Cells: ENHANCED by Mom	45
Blood Plasma Proteome-Wide Association Study Implicates New Proteins in Type 2 Diabetes Mellitus Pathogenesis	45
Effects of Maternal Exercise Modes on Glucose and Lipid Metabolism in Offspring Stem Cells	45
Cognitive Function in Individuals with Chronic Hypoparathyroidism—A Prospective Observational Study	45
Mid-to Long-term Outcomes After Single Radiofrequency Ablation of Nontoxic and Toxic Thyroid Nodules	44
Circulating plasma follistatin follows a 24-hour rhythm in healthy young males	44
Tirzepatide Heralds the Hope of Chronic Disease Eradication	44
Interim Effects of Zoledronate, Denosumab, or Teriparatide on Bone Microarchitecture in Type 2 Diabetes: A Pilot Trial	44
Long-acting growth hormone for treating growth hormone deficiency in children: a meta-analysis of randomized controlled trials focusing on changes in body mass index	43
Prospective Multicenter Registry–Based Study on Thyroid Storm: The Guidelines for Management From Japan Are Useful	43

Insulin Sensitivity and Insulin Secretion in Adults With Friedreich's Ataxia: The Role of Skeletal Muscle	43
Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves’ Disease	42
Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman	42
Remnant Cholesterol Is Associated With Gestational Diabetes Mellitus: A Cohort Study	42
High Incidence of Diabetes Mellitus After Distal Pancreatectomy and Its Predictors: A Long-term Follow-up Study	42
Polycystic Ovary Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci	42
Machine Learning Prediction of Recurrence in Pediatric Thyroid Cancer: Malignant Endocrine Tumors Cohort Analysis Using XGBoost and SHAP	41
Impact of Newborn Screening on Adult Height in Patients With Congenital Adrenal Hyperplasia (CAH)	41
Severity of MASH activity by iron-corrected MRI predicts insulin resistance and cardiometabolic risk in type 2 diabetes	41
Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases	41
Correction to “Treatment of Hyperthyroidism Reduces Systemic Oxidative Stress, as Measured by Markers of RNA and DNA Damage”	40
Sequential Therapy for the Long-Term Treatment of Postmenopausal Osteoporosis	40
Response to Letter to the Editor From Han and Xu: “Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes”	40
Correction to “Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline”	40
Correction to: “Adult Height Following Prepubertal Treatment With Antiandrogen, Aromatase Inhibitor, and Reduced Hydrocortisone in CAH”	39
Response to Letter to the Editor from Hao and Xue: “Checkpoint Inhibitor-associated Autoimmune Diabetes Mellitus Is Characterized by C-Peptide Loss and Pancreatic Atrophy”	39
Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia Estimated by Oral D-[6,6-2H2]-glucose	39
What Is the Role for Pediatric Endocrinologists in the Management of Skeletal Dysplasias?	39
Does the Duration of Diabetes Matter When Evaluating the Risk of Heart Failure?	39
Precision Medicine in Acromegaly: The Potential of Multimodal Therapy	39
IGF-1/IGFBP-3 Serum Ratio as a Robust Measure to Determine GH Deficiency and Guide Human Recombinant GH Therapy	39
The Impact of Acute Nutritional Interventions on the Plasma Proteome	38
Correction to: “Approach to the Patient: Reninoma”	38
Altered Microbiome Signature in Cushing's Syndrome Persists Beyond Remission	38
Response to Letter to the Editor from de Zegher and Ibáñez: “Rare Variation in LMNA Underlies Polycystic Ovary Syndrome (PCOS) in Two Independent Cohorts”	38
New Insights on the Environment of Sex Steroids in Adipose Tissue of Postmenopausal Women at Hormone Therapy	38
Effects of Rare Coding Variants in Severe Early-Onset Obesity Genes in the Population-Based UK Biobank Study	38
Metabolic Effects of Glucagon Stimulations in Type 1 Diabetes and Healthy Controls	38
Correction to: “Reassuring Data on the Cardiovascular Risk in Adults With X-linked Hypophosphatemia Receiving Conventional Therapy”	37
Sleep Patterns, Plasma Metabolome, and Risk of Incident Type 2 Diabetes Mellitus	36
Prevalence of Cortisol Cosecretion in Patients With Primary Aldosteronism: Role of Metanephrine in Adrenal Vein Sampling	36
Metabolic and muscular effects of switching from somatropin to somapacitan in adults with growth hormone deficiency	36
Mineralocorticoid Receptor and Aldosterone: Interaction Between NR3C2 Genetic Variants, Sex, and Age in a Mixed Cohort	36
Low T3 Syndrome on Admission and Response to Nutritional Support in Malnourished Medical Inpatients	36
Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine	36
Exclusion Tests in Unilateral Primary Aldosteronism (ExcluPA) Study	36
Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management	36
Dyslipidemia Is Associated With Increased Natural Killer Cell Cytotoxicity and Autoimmunity in Women With Recurrent Pregnancy Losses	35
Approach to the Patient: Low Testosterone Concentrations in Men With Obesity	35
Mortality risk and causes of death in exogenous Cushing's syndrome: a systematic review and meta-analysis	35
Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test	35
Early Detection of Relapse by ctDNA Sequencing in a Patient with Metastatic Thymic Tumor and MEN1 Mosaicism	35
New Avenues for Pharmacological Management of Hyperphagia and Associated Behavioral Disorders in Prader-Willi Syndrome	34
Denosumab and Risk of Community-acquired Pneumonia: A Population-based Cohort Study	34
The Multifaceted Roles of Bone Marrow Adipocytes in Bone and Hematopoietic Homeostasis	34
A Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid Carcinoma	34
Association of Glucose Response Shape in OGTT With Markers of Pancreatic Health and Inflammation Across Diverse Ages	33
Total and Regional Fat-To-Muscle Mass Ratio in Relation to All-Cause and Cause-Specific Mortality in Men and Women	33
Outcomes and Therapeutic Strategies for Head-and-neck Paragangliomas Associated With Succinate Dehydrogenase Mutations	33
Genetic Underpinnings of Fasting and Oral Glucose-stimulated Based Insulin Sensitivity Indices	33
Cognitive Risk Stratification Score in Middle-aged and Older Adults With Type 2 Diabetes: A Cross-Sectional Study	33
Central Hypothyroidism is Frequent During Mitotane Therapy in Adrenocortical Cancer Patients: Prevalence and Timeline	33
Three-Year Observation of Glucose Metabolism After Pancreaticoduodenectomy: A Single-Center Prospective Study in Japan	33
Insulin Receptor Family Autoantibodies in Patients with Type B Insulin Resistance	32
Increased Prevalence of Germline Pathogenic CHEK2 Variants in Individuals With Pituitary Adenomas	32
Genetic Variants Associated With Mineral Metabolism Traits in Chronic Kidney Disease	32
Dose-related Effects of Calcium to Enhance the Effects of L-tryptophan on Gut Hormones and Energy Intake in Obesity	32
Serum Klotho Modifies the Associations of 25-Hydroxy Vitamin D With All-Cause and Cardiovascular Mortality	32
Back to the Drawing Board: Rethinking Inflammation in Polycystic Ovary Syndrome	32
Taming Idiopathic Central Precocious Puberty: High Frequency of Imprinting Disorders in Familial Forms	31
RETRACTED AND REPLACED: Comparison of Cumulative Live Birth Rates Between Progestin and GnRH Analogues in Preimplantation Genetic Testing Cycles	31
A Global Approach to the Long-Term Follow-Up of 17 Families With Bilateral Macronodular Adrenal Disease	31
Higher Plasma Levels of Endocannabinoids and Analogues Correlate With a Worse Cardiometabolic Profile in Young Adults	31
Associations of Serum 25(OH)D With Risk of Recurrent Cardiovascular Events in Individuals With Coronary Heart Disease	31
Current Practices in Monitoring Children and Adults With X-linked Hypophosphatemia: A Global Survey of Expert Experience	31
Comparative Efficacy of Radioiodine Therapy With Adjunctive Thionamides vs Either Treatment Alone in the Management of Graves Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Tr	31
Subtle Cognitive Impairments and Psychological Complaints in Patients With Prolactinoma Despite Biochemical Control	31
RBP4-based Multimarker Score: A Prognostic Tool for Adverse Cardiovascular Events in Acute Coronary Syndrome Patients	31
Subclinical ocular alterations in Graves' disease: The FUMO score, a new tool to predict Graves' orbitopathy progression	31
Correction to: “Children With Pancreatic Hypoplasia Experience Poor Weight Gain and Labile Diabetes but Low Incidence of DKA”	30
Racial/Ethnic Inequities in Use of Diabetes Technologies Among Medicare Advantage Beneficiaries With Type 1 Diabetes	30
Serum DHEA and Testosterone Levels Associate Inversely With Coronary Artery Calcification in Elderly Men	30
Low-Quality Carbohydrate Intake Is Associated With a Higher Prevalence of Metabolic Syndrome: The AWHS Study	30
Aggressive Subtypes of Papillary Microcarcinoma	30
Association Between Systemic Lupus Erythematosus and Primary Hypothyroidism: Evidence from Complementary Genetic Methods	30
Disordered Eating Behaviors During Adolescence and Risk of Polycystic Ovary Syndrome: A Prospective Cohort Study	30
Triglyceride–Glucose Index and Risks of All-Cause and Cause-Specific Mortality in Young Adults	30
Effects of Puberty Suppression and Sex Steroids on Weight, BMI, and Lipid Profiles in Danish Transgender Adolescents	30
Pancreatic Cancer Screening in New-onset and Deteriorating Diabetes: Preliminary Results From the PANDOME Study	30
Correction to: Iron Overload in Functional Hyperandrogenism: In a Randomized Trial, Bloodletting Does Not Improve Metabolic Outcomes	29

Higher FSH Level Is Associated With Increased Risk of Incident Hip Fracture in Older Adults, Independent of Sex Hormones	29
Correction to “Reduced Sensitivity to Thyroid Hormones Is Associated With High Remnant Cholesterol Levels in Chinese Euthyroid Adults”	29
Correction to “β-Cell Function and Insulin Sensitivity in Youth With Early Type 1 Diabetes From a 2-Hour 7-Sample OGTT”	29
Long-term Efficacy and Safety of Pasireotide in Patients With Acromegaly: 14 Years of Single-Center Real-World Experience	29
Correction to: “Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination”	29
MeIS: DNA Methylation-Based Immune Response Signatures for Thyroid Nodule Diagnostics	29
Risk of Type 2 Diabetes, MASLD and Cardiovascular Disease in People Living With Polycystic Ovary Syndrome	29
Correction to: “Effect of Waiting Time for Radioactive Iodine Therapy on Outcome in N1 Stage Papillary Thyroid Cancer”	28
A Nested Case–Control Study of Adverse Outcomes in Children With Diabetic Ketoacidosis	28
Understanding Epigenetic Factors on Adiponectin	28
Human GH Use By Athletes With Short Stature Without GH Deficiency: Therapeutic Use Exemptions	28
Letter to the Editor from Han and Xu: “Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes”	28
Correction to “Gut Microbiota Composition and Functionality Are Associated With REM Sleep Duration and Continuous Glucose Levels”	28
Response to Letter to the Editor From Xu and Yang: “Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study)”	28
Diabetes Duration and the Reverse Impact Between Cholesterol Levels and Risk Among Individuals With Type 2 Diabetes	28
Inhibiting Soluble Epoxide Hydrolase Suppresses NF-κB p65 Signaling and Reduces CXCL10 Expression as a Potential Therapeutic Target in Hashimoto's Thyroiditis	28
Letter to the Editor From Watts and Leslie: Comparisons Between Different Antiosteoporosis Medications on Postfracture Mortality: A Population-based Study	28
Effect of Oral Bisphosphonate Drug Holiday on Mortality Following Hip Fracture	28
New Hope for a Tumor-Directed Therapy for Cushing Disease	28
Correction to: Temporal Trends in Outcomes in Patients with Adrenocortical Carcinoma: A Multidisciplinary Referral Center Experience	28
Skeletal Effects of Sleeve Gastrectomy, by Sex and Menopausal Status and Compared to Roux-En-Y Gastric Bypass Surgery	28
Analysis of Delayed Surgery and Clinical Outcomes in Intermediate- and High-risk Papillary Thyroid Cancer	27
Long-Term Glycemic Variability Predicts Adverse Outcomes in Diabetic Heart Failure With Preserved Ejection Fraction	27
Genetic Variants Associated With the Biochemical Response to Vitamin D3 in the Multi-Ethnic Study of Atherosclerosis	27
Endocrine Responses to Triptorelin in Healthy Women, Women With Polycystic Ovary Syndrome, and Women With Hypothalamic Amenorrhea	27
Alteration of Bone Microarchitecture in Hereditary Distal RTA Patients With SLC4A1 Gene Mutation: Assessed by HR-pQCT	27
Glycemic Management Around Postprandial Exercise in People With Type 1 Diabetes: Challenge Accepted	27
Response to Letter to the Editor from Flood and Hackney: Myofibrillar protein synthesis rates do not differ with low and high estradiol concentrations across the menstrual cycle	27
Letter to the Editor From de Zegher and Ibáñez: “Rare Variation in LMNA Underlies Polycystic Ovary Syndrome Pathogenesis in 2 Independent Cohorts”	27
A Possible New Biomarker for T1D? : RNA Splicing in Circulating Blood	27
Beyond Malignancy Risk Stratification: FNAC Report Anticipates Thyroid Cancer Staging. Insights From Recent Studies	27
Age-Stratified Reference Ranges for Directly Measured Serum Free Testosterone in Community-Dwelling and Healthy Men	27
Impact of SGLT2 Inhibitors on Glomerular Filtration in Type 1 Diabetes	27
Signs of Glucagon Resistance After a 2-Week Hypercaloric Diet Intervention	26
New Horizons: the value of UK Biobank to research on endocrine and metabolic disorders	26
Cardiometabolic Risk Assessment in Transgender Individuals—Differential Effect of Sex Hormones and Sex Chromosomes	26
Permanent vs Transient Congenital Hypothyroidism in Chinese Children: Physical Growth and Predictive Nomogram	26
Basal Hyperglycemia Contributes More Than 50% to Time in Range in Pregnant Women With Type 1 Diabetes	26
The Association Between Pregnancy Complications and Long-term Maternal Cardiometabolic Health in the MIREC Cohort Study	26
Trends in Osteoporosis Drug Therapy Receipt Among Commercial and Medicare Advantage Enrollees in the United States, 2011-2022	26
Sex Hormones Mediate Intensive Lifestyle Intervention–Induced Bone Mineral Density Changes: Look AHEAD Sex Hormone Study	26
Longitudinal Changes in Sex Hormones in a Population of Older Community-dwelling Men	26
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity	26
Hyperglycemia Suppresses Lactate Clearance During Exercise in Type 1 Diabetes	25
The Association of Female and Male Preconception Dyslipidemia With Live Birth in Couples Seeking Fertility Treatment	25
Impact of Setmelanotide on Metabolic Syndrome Risk in Patients With Bardet-Biedl Syndrome	25
Altered Static and Dynamic Brain Functional Topological Organization in Patients With Dysthyroid Optic Neuropathy	25
At any Level of Adiposity, Relatively Elevated Leptin Concentrations Are Associated With Decreased Insulin Sensitivity	25
Real-World Osilodrostat Effectiveness and Safety in Nonpituitary Cushing Syndrome	25
Phthalates and Incident Diabetes in Midlife Women: The Study of Women's Health Across the Nation (SWAN)	25
Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries	25
Prediagnostic Vitamin D Status and Colorectal Cancer Survival by Vitamin D Binding Protein Isoforms in US Cohorts	25
Approach to the Patient: Diagnosis of Cushing Syndrome	25
Approach to the Patient With Parathyroid Carcinoma	24
Metabolic Phenotype of Stage 1 and Stage 2 Type 1 Diabetes Using Modeling of β Cell Function	24
Gonadal Function and Its Evolution in 46,XX Testicular/Ovotesticular DSD	24
Compartment-specific Metabolic Alterations to Insulin Reflect Adiposity-driven Variation and Predict Type 2 Diabetes	24
Progressive 11β-Hydroxysteroid Dehydrogenase Type 2 Insufficiency as Kidney Function Declines	24
Maternal Thyroid Function: Does It Have a Role in Fetal Programming and Later Offspring Growth?	24
Machine Learning–Based Survival Prediction Tool for Adrenocortical Carcinoma	24
An Interpretable Machine-Learning Model for Predicting Occult Central Lymph Node Metastasis in Papillary Thyroid Cancer	24
It's Not Just About the Hot Flashes: Menopausal Hormone Changes and Disrupted Sleep	24
Adrenal Venous Sampling Via an Antecubital Approach in Primary Aldosteronism: A Multicenter Study	24
New Insights in the Pathophysiology, Epidemiology, and Response to Treatment of Osteoporotic Vertebral Fractures	24
Machine Learning–Based Biomarker Identification for Early Diagnosis of Metabolic Dysfunction–Associated Steatotic Liver Disease	24
Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France	24
Kidney Function in Patients With Adrenal Adenomas: A Single-Center Retrospective Cohort Study	23
Comparison of Efficacy of Romosozumab With Denosumab and Risedronate in Patients Newly Initiating Glucocorticoid Therapy	23
Molecular Profiling of Low-Risk Papillary Thyroid Carcinoma (mPTC) on Active Surveillance	23
Role of Sex Hormones in Mediating Adiposity Changes From Weight Loss in People With Type 2 Diabetes: Look AHEAD Sex Hormone Study	23
X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline	23
Letter to the Editor From Banigé and Polak: “Population-based TSH Screening of Newborns for Hyperthyroidism: It May Be Feasible, But Is It Justified?”	23
Screening for Adverse Metabolic Consequences in Women With Idiopathic Hirsutism—Is it Relevant?	23
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline	23
Skewness in Body fat Distribution Pattern Links to Specific Cardiometabolic Disease Risk Profiles	23
Serum Concentrations of Inhibin B in Healthy Females and Males Throughout Life	23
Safety, Growth, and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up)	23
GH Treatment in Children of Normal Height	23
Adipose Tissue Dysfunction in Polycystic Ovary Syndrome	23
Correction to: “Cardiovascular Safety of Romosozumab vs PTH Analogues for Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study”	23
Response to the Letter From Kloos: “Evaluation of Female Fertility – AMH and Ovarian Reserve Testing”	23
Development of a New Model of Insulin Sensitivity in Patients With Type 2 Diabetes and Association With Mortality	23
Comparison of Different Diagnostic Criteria of 68Ga-Pentixafor PET/CT for the Classification of Primary Aldosteronism	23
Prolonged Hypokalemia and Delayed Diagnosis of Primary Aldosteronism: Clinical Course and Risk Factors	23
Somatic Activating ESR1 Mutation in an Aggressive Prolactinoma	23
Novel Cardiometabolic Medications in the Cardiovascular-Kidney-Metabolic Syndrome Era	23
Shaping the Skeleton: Impact of GnRH Analogue and Sex Hormone Therapy on Skeletal Dimensions in Transgender Individuals	23
Letter to the Editor From Tang and Zhang: “Predictors of Cardiovascular Morbidities in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia”	23
Approach to the Patient with Achondroplasia—New Considerations for Diagnosis, Management, and Treatment	23
Correction to: “Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice Guideline”	22
Improving the Risk Prediction of the 2015 ATA Recurrence Risk Stratification in Papillary Thyroid Cancer	22
Islet Inflammation Can Be Linked to the Disruption of Proinsulin Processing in Type 1 Diabetes but not in Type 2 Diabetes	22
Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS	22
Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study	22
Development of Spinal Enthesopathies in Adults With X-linked Hypophosphatemia	22